Istvan Enyedy

2.2k total citations
46 papers, 1.3k citations indexed

About

Istvan Enyedy is a scholar working on Molecular Biology, Computational Theory and Mathematics and Organic Chemistry. According to data from OpenAlex, Istvan Enyedy has authored 46 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 14 papers in Computational Theory and Mathematics and 10 papers in Organic Chemistry. Recurrent topics in Istvan Enyedy's work include Computational Drug Discovery Methods (14 papers), Receptor Mechanisms and Signaling (10 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). Istvan Enyedy is often cited by papers focused on Computational Drug Discovery Methods (14 papers), Receptor Mechanisms and Signaling (10 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). Istvan Enyedy collaborates with scholars based in United States, China and Switzerland. Istvan Enyedy's co-authors include Shaomeng Wang, William J. Egan, Sukumar Sakamuri, Ingo Muegge, Kenneth M. Johnson, Alan P. Kozikowski, Ya‐Qiu Long, Peter P. Roller, Chen‐Yong Lin and Robert B. Dickson and has published in prestigious journals such as Journal of the American Chemical Society, Biochemical Journal and Journal of Medicinal Chemistry.

In The Last Decade

Istvan Enyedy

46 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Istvan Enyedy United States 22 870 364 337 141 119 46 1.3k
Yongbo Hu United States 23 1.2k 1.3× 402 1.1× 368 1.1× 159 1.1× 135 1.1× 60 1.9k
Jon Read United Kingdom 25 1.3k 1.5× 369 1.0× 227 0.7× 199 1.4× 106 0.9× 40 2.1k
Owen B. Wallace United States 16 689 0.8× 403 1.1× 405 1.2× 131 0.9× 80 0.7× 27 1.6k
Johannes Voigt United States 23 1.0k 1.2× 351 1.0× 513 1.5× 227 1.6× 176 1.5× 42 1.5k
Mario Cardozo United States 18 773 0.9× 552 1.5× 233 0.7× 171 1.2× 139 1.2× 31 1.4k
Andrew Anighoro Italy 12 837 1.0× 256 0.7× 490 1.5× 176 1.2× 175 1.5× 21 1.2k
Masaya Orita Japan 24 848 1.0× 285 0.8× 232 0.7× 151 1.1× 104 0.9× 58 1.4k
Huiping Zhao United States 26 968 1.1× 277 0.8× 313 0.9× 175 1.2× 104 0.9× 58 1.6k
Megan L. Peach United States 20 745 0.9× 345 0.9× 324 1.0× 119 0.8× 163 1.4× 50 1.2k
Yaxia Yuan United States 22 1.2k 1.3× 283 0.8× 394 1.2× 325 2.3× 156 1.3× 60 1.7k

Countries citing papers authored by Istvan Enyedy

Since Specialization
Citations

This map shows the geographic impact of Istvan Enyedy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Istvan Enyedy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Istvan Enyedy more than expected).

Fields of papers citing papers by Istvan Enyedy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Istvan Enyedy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Istvan Enyedy. The network helps show where Istvan Enyedy may publish in the future.

Co-authorship network of co-authors of Istvan Enyedy

This figure shows the co-authorship network connecting the top 25 collaborators of Istvan Enyedy. A scholar is included among the top collaborators of Istvan Enyedy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Istvan Enyedy. Istvan Enyedy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Shifan, Mark McGann, & Istvan Enyedy. (2021). The influence of calculated physicochemical properties of compounds on their ADMET profiles. Bioorganic & Medicinal Chemistry Letters. 36. 127825–127825. 6 indexed citations
2.
Xin, Zhili, J. Howard Jones, Istvan Enyedy, et al.. (2020). Discovery of CNS-Penetrant Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitors. ACS Medicinal Chemistry Letters. 11(4). 485–490. 16 indexed citations
3.
Ravna, Aina Westrheim, et al.. (2020). Identification and experimental confirmation of novel cGMP efflux inhibitors by virtual ligand screening of vardenafil-analogues. Biomedicine & Pharmacotherapy. 126. 110109–110109. 10 indexed citations
4.
Ma, Bin, Brian S. Lucas, Andrew G. Capacci, et al.. (2019). Design, synthesis and identification of novel, orally bioavailable non-covalent Nrf2 activators. Bioorganic & Medicinal Chemistry Letters. 30(4). 126852–126852. 30 indexed citations
5.
Enyedy, Istvan, Noel A. Powell, Justin A. Caravella, et al.. (2016). Discovery of biaryls as RORγ inverse agonists by using structure-based design. Bioorganic & Medicinal Chemistry Letters. 26(10). 2459–2463. 12 indexed citations
6.
Banerjee, Daliya, Tonika Bohnert, Jianhua Chao, et al.. (2015). Discovery of novel pyrazole-containing benzamides as potent RORγ inverse agonists. Bioorganic & Medicinal Chemistry Letters. 25(15). 2985–2990. 27 indexed citations
7.
Chao, Jianhua, Istvan Enyedy, D.J. Marcotte, et al.. (2015). Discovery of biaryl carboxylamides as potent RORγ inverse agonists. Bioorganic & Medicinal Chemistry Letters. 25(15). 2991–2997. 27 indexed citations
8.
Ishchenko, Alexey, Lin Zhang, Junhua Fan, et al.. (2014). Structure-based design of low-nanomolar PIM kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(3). 474–480. 17 indexed citations
9.
Fu, Ting, et al.. (2013). Role of Bivalent Cations in Structural Stabilities of New Drug Targets ——Vacciniarelated Kinases (VRK) from Molecular Dynamics Simulations. Current Pharmaceutical Design. 19(12). 2269–2281. 2 indexed citations
10.
Gamber, Gabriel G., Erik L. Meredith, Michael Capparelli, et al.. (2011). 3,5-Diarylazoles as novel and selective inhibitors of protein kinase D. Bioorganic & Medicinal Chemistry Letters. 21(5). 1447–1451. 27 indexed citations
11.
Muegge, Ingo & Istvan Enyedy. (2004). Virtual Screening for Kinase Targets. Current Medicinal Chemistry. 11(6). 693–707. 51 indexed citations
12.
Sakamuri, Sukumar, Istvan Enyedy, Srihari R. Tella, et al.. (2003). 2,3-Disubstituted quinuclidines as a novel class of dopamine transporter inhibitors. Bioorganic & Medicinal Chemistry. 11(6). 1123–1136. 4 indexed citations
13.
Enyedy, Istvan, et al.. (2003). Pharmacophore-Based discovery of substituted pyridines as novel dopamine transporter inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(3). 513–517. 74 indexed citations
14.
15.
Enyedy, Istvan, et al.. (2001). Pharmacophore-based discovery of 3,4-disubstituted pyrrolidines as a novel class of monoamine transporter inhibitors. Bioorganic & Medicinal Chemistry Letters. 11(9). 1113–1118. 39 indexed citations
16.
Enyedy, Istvan, Ildiko M. Kovach, & Ákos Bencsura. (2001). Molecular dynamics study of active-site interactions with tetracoordinate transients in acetylcholinesterase and its mutants. Biochemical Journal. 353(3). 645–645. 8 indexed citations
17.
18.
Sakamuri, Sukumar, et al.. (2001). Pharmacophore-Based discovery, synthesis, and biological evaluation of 4-phenyl-1-arylalkyl piperidines as dopamine transporter inhibitors. Bioorganic & Medicinal Chemistry Letters. 11(4). 495–500. 25 indexed citations
19.
Long, Ya‐Qiu, Chen‐Yong Lin, Istvan Enyedy, et al.. (2001). Synthesis and evaluation of the sunflower derived trypsin inhibitor as a potent inhibitor of the type II transmembrane serine protease, matriptase. Bioorganic & Medicinal Chemistry Letters. 11(18). 2515–2519. 66 indexed citations
20.
Tamiz, Amir P., Miles P. Smith, Istvan Enyedy, et al.. (2000). Synthesis and biological evaluation of 1-azabicyclo-[3.2.1]octanes: new dopamine transporter inhibitors. Bioorganic & Medicinal Chemistry Letters. 10(15). 1681–1686. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yongbo Hu Breakdown of academic impact, for papers by Jon Read Breakdown of academic impact, for papers by Owen B. Wallace Breakdown of academic impact, for papers by Johannes Voigt Breakdown of academic impact, for papers by Mario Cardozo Breakdown of academic impact, for papers by Andrew Anighoro Breakdown of academic impact, for papers by Masaya Orita Breakdown of academic impact, for papers by Huiping Zhao Breakdown of academic impact, for papers by Megan L. Peach Breakdown of academic impact, for papers by Yaxia Yuan
Rankless by CCL
2026